Relationship between basal NO release and cyclooxygenase products in the normal rat kidney

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Baylis, Chris ^a   Slangen, Brigitte ^b   Hussain, Sarah ^b   Weaver, Carol ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

blood pressure; conscious, chronically catheterized rat; glomerular filtration rate; renal vascular resistance; sodium excretion

Indexed keywords

INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CATHETERIZATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0029910415     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.5.r1327     Document Type: Article

References (33)

1. Bachmann, S., and P. Mundel. NO in the kidney: synthesis, localization and function. Am. J. Kidney Dis. 24: 112-129, 1994.
2. Ballerman, B. J., D. J. Levenson, and B. M. Brenner. Renin, angiotensin, kinins, prostaglandins, and leukotrienes. In: The Kidney, edited by B. M. Brenner and F. C. Rector, Jr. Philadelphia, PA: Saunders, 1986, chapt. 9, p. 281-340.
3. Baylis, C., and B. M. Brenner. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ. Res. 43: 889-898, 1978.
4. Baylis, C., K. Engels, L. Samsell, and P. Harton. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F74-F78, 1993.
5. Baylis, C., P. Harton, and K. Engels. Endothelial derived relaxing factor (EDRF) controls renal hemodynamics in the normal rat kidney. J. Am. Soc. Nephrol. 1: 875-881, 1990.
6. Baylis, C., J. Harvey, and K. Engels. Acute NO amplifies the renal vasoconstrictor actions of angiotensin II. J. Am. Soc. Nephrol. 5: 211-214, 1994.
7. Deng, A., and C. Baylis. Locally produced EDRF control preglomerular resistance and the ultrafiltration coefficient Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F212-F215, 1993.
8. Doni, M. G., B. J. R. Whittle, R. M. J. Palmer, and S. Moncada. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur. J. Pharmacol. 151: 19-25, 1988.
9. Gaillard, T., A. Mulsch, H. Klein, and K. Decker. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler 373: 897-902, 1992.
10. Granger, J. P., A. M. Alberola, F. J. Salazar, and T. Nakamura. Control of renal hemodynamics during intrarenal, and systemic blockade of NO synthesis in conscious dogs. J. Cardiovasc. Pharmacol. 20, Suppl.: S160-S162, 1992
11. Gryglewski, R. J. Interactions between NO and prostacyclin, Semin. Thromb. Hemostasis 19: 158-166, 1993.
12. Hardie, W. D., J. Ebert, M. Frazer, K. Takahashi, and K. Badr. The effect of thromboxane A2 receptor antagonism on amphotericin B induced renal vasoconstriction in the rat. Prostaglandins 45: 47-56, 1993.
13. Koide, M., Y. Kawahara, I. Nakyama, T. Tsuda, and M. Yokoyama. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J. Biol. Chem. 268: 24959-24966, 1993.
14. G-monomethyl-L-arginine, and L-arginine on acetylcholine renal response. Hypertension Dallas 15: 659-663, 1990.
15. Lahera, V., M. G. Salom, M. J. Fiksen-Olsen, and J. C. Romero. Mediatory role of endothelium-derived NO in renal vasodilatory, and excretory effects of bradykinin. Am. J. Hypertens. 4: 260-262, 1991.
16. G-nitro-L-arginine methyl ester on renal function, and blood pressure. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1033-F1037, 1991.
17. Luckhoff, A., A. Mulsch, and R. Busse. cAMP attenuates autacoid release from endothelial cells: relation to internal calcium. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H960-H966, 1990.
18. Marotta, P., L. Sautebin, and M. Di Rosa. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107: 640-641, 1992.
19. Moncada, S., R. M. J. Palmer, and E. A. Higgs. NO: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-141, 1991.
20. Muhl, H., D. Kunz, and J. Pfeilschifter. Expression of NO synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br. J. Pharmacol. 112: 1-8, 1994.
21. Munger, K. A., and C. Baylis. Sex differences in renal hemodynamic in rats. Am. J. Physiol. 254 (Renal Fluid Electrolyte Physiol. 23): F223-F231, 1988.
22. ω-nitro-L-arginine methyl ester administration. J. Cardiovasc. Pharmacol. 23: 765-771, 1994.
23. Qiu, C., K. Engels, and C. Baylis. Importance of angiotensin II, and α1-adrenergic tone in chronic NO inhibition-induced hypertension in conscious rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1470-R1476, 1994.
24. Qiu, C., K. Engels, L. Samsell, and C. Baylis. Renal effects of amino acid infusion in chronic nitric oxide blockade-induced hypertension. Hypertension Dallas 25: 61-66, 1995.
25. Raij, L., and C. Baylis. Nitric oxide and the glomerulus (Editorial Review). Kidney Int. 48: 20-32, 1995.
26. Ruiz, F. J., A. C. Ingles, T. Quesada, M. G. Salom, and L. F. Carbonell. Indomethacin does not modify the role of nitric oxide on blood pressure regulation of SHR. Gen. Pharmacol. 25: 103-106, 1994.
27. Salvemini, D., S. Seibert, J. L. Masferrer, T. P. Misko, M. G. Currie, and P. Needleman. Endogenous NO enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93: 1940-1947, 1994.
28. Sautebin, L., A. Ialenti, A. Ianaro, and M. Di Rosa. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol. 114: 323-328, 1995.
29. Tolins, J. P., R. M. J. Palmer, S. Moncada, and L. Raij. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H655-H662, 1990.
30. Walder, C. E., C. Thiemermann, and J. R. Vane. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br. J. Pharmacol. 102: 967-973, 1991.
31. Welch, W. J., C. S. Wilcox, K. Aisaka, S. S. Gross, O. W. Griffith, B. M. A. Fontoura, T. Maack, and R. Levi. NO synthesis from L-arginine modulates renal vascular resistance in isolated perfused and intact rat kidneys. J. Cardiovasc. Pharmacol. 17, Suppl.: S165-S168, 1991.
32. Whelton, A., and C. W. Hamilton. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J. Clin. Pharmacol. 31: 588-598, 1991.
33. Zhang, B. L., K. L. Liu, D. Benzoni, and J. Sassard. Nitric oxide, and eicosinoid interactions in kidneys of Lyon hypertensive rats. J. Hyperten. 11, Suppl. 5: S136-S137, 1993.